118 related articles for article (PubMed ID: 9517956)
1. Antimicrobial activity of novel furanonaphthoquinone analogs.
Nagata K; Hirai KI; Koyama J; Wada Y; Tamura T
Antimicrob Agents Chemother; 1998 Mar; 42(3):700-2. PubMed ID: 9517956
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of a new series of 1,4-naphthoquinones.
Riffel A; Medina LF; Stefani V; Santos RC; Bizani D; Brandelli A
Braz J Med Biol Res; 2002 Jul; 35(7):811-8. PubMed ID: 12131921
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationship Studies of Antimicrobial Naphthoquinones Derived from Constituents of Tabebuia avellanedae.
Yamashita M; Sawano J; Umeda R; Tatsumi A; Kumeda Y; Iida A
Chem Pharm Bull (Tokyo); 2021; 69(7):661-673. PubMed ID: 34193715
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus.
Machado TB; Pinto AV; Pinto MC; Leal IC; Silva MG; Amaral AC; Kuster RM; Netto-dosSantos KR
Int J Antimicrob Agents; 2003 Mar; 21(3):279-84. PubMed ID: 12636992
[TBL] [Abstract][Full Text] [Related]
5. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the antibacterial and antifungal activity of thiolated naphthoquinones.
Wellington KW; Nyoka NBP; McGaw LJ
Drug Dev Res; 2019 May; 80(3):386-394. PubMed ID: 30609114
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Jansen WT; Verel A; Verhoef J; Milatovic D
Antimicrob Agents Chemother; 2007 Sep; 51(9):3420-4. PubMed ID: 17606689
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
Malathum K; Coque TM; Singh KV; Murray BE
Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
11. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial properties of some cyclic organobismuth(III) compounds.
Kotani T; Nagai D; Asahi K; Suzuki H; Yamao F; Kataoka N; Yagura T
Antimicrob Agents Chemother; 2005 Jul; 49(7):2729-34. PubMed ID: 15980343
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activities of naphthazarins from Arnebia euchroma.
Shen CC; Syu WJ; Li SY; Lin CH; Lee GH; Sun CM
J Nat Prod; 2002 Dec; 65(12):1857-62. PubMed ID: 12502328
[TBL] [Abstract][Full Text] [Related]
16. Decade-long use of the antimicrobial peptide combination tyrothricin does not pose a major risk of acquired resistance with gram-positive bacteria and Candida spp.
Stauss-Grabo M; Atiye S; Le T; Kretschmar M
Pharmazie; 2014 Nov; 69(11):838-41. PubMed ID: 25985581
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the antimicrobial property of the stem bark of Picralima nitida (Apocynaceae).
Fakeye TO; Itiola OA; Odelola HA
Phytother Res; 2000 Aug; 14(5):368-70. PubMed ID: 10925406
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.
Adachi Y; Nakamura K; Kato Y; Hazumi N; Hashizume T; Nakagawa S
Antimicrob Agents Chemother; 1997 Oct; 41(10):2282-5. PubMed ID: 9333063
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activities of lichen-derived compounds against methicillin- and multidrug-resistant Staphylococcus aureus.
Kokubun T; Shiu WK; Gibbons S
Planta Med; 2007 Feb; 73(2):176-9. PubMed ID: 17415880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
